Home β€Ί Healthcare β€Ί Medical Devices β€Ί Drug Eluting Implants Market

Drug Eluting Implants Market Report, Size, Share, Opportunities, and Trends Segmented By Product Type, Material, Application, End-User, and Geography – Forecast from 2025 to 2030

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Market Size
USD 10.133 billion
by 2031
CAGR
6.03%
2026-2031
Base Year
2025
Forecast Period
2026-2031
Projection
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. DRUG ELUTING IMPLANTS MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Drug Eluting Stents

5.3. Contraceptive Implants

5.4. Drug Eluting Vascular Grafts

5.5. Others

6. DRUG ELUTING IMPLANTS MARKET BY MATERIAL

6.1. Introduction

6.2. Biodegradable

6.3. Non-Biodegradable

7. DRUG ELUTING IMPLANTS MARKET BY APPLICATION

7.1. Introduction

7.2. Oncology

7.3. Opthalmology

7.4. Cardiology

7.5. Contraception/Birth Control

7.6. Others

8. DRUG ELUTING IMPLANTS MARKET BY END-USER

8.1. Introduction

8.2. Hospital

8.3. Ambulatory Surgical Centers

8.4. Others

9. DRUG ELUTING IMPLANTS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Italy

9.4.5. Spain

9.4.6. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Taiwan

9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. iVascular

11.2. ProMed Pharma

11.3. Boston Scientific Corporation

11.4. Merck Group

11.5. Medtronic, Inc.

11.6. Biosensors International Group

11.7. Abbott Laboratories

11.8. Elixir Medical Corporation

11.9. Biotronik SE & Co. KG

11.10. Lubrizol 

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

REPORT DETAILS

Report ID:KSI061611191
Published:Nov 2025
Pages:148
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us